Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain.
about
Ketamine as an adjuvant to opioids for cancer painKetamine as an adjuvant to opioids for cancer painKetamine: 50 Years of Modulating the MindReview article: palliative care in gynecologic oncology.Oral ketamine in the palliative care setting: a review of the literature and case report of a patient with neurofibromatosis type 1 and glomus tumor-associated complex regional pain syndromeAdjuvant ketamine analgesia for the management of cancer pain.Ketamine for the treatment of depression in patients receiving hospice care: a retrospective medical record review of thirty-one casesOral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care.Ketamine as an analgesic: parenteral, oral, rectal, subcutaneous, transdermal and intranasal administration.Morphine is not the only analgesic in palliative care: literature review.Ketamine Injection among High Risk Youth: Preliminary Findings from New York City.The rationale for a multimodal approach in the management of breakthrough cancer pain: a review.Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trial.HIV Sexual Risk Behaviors among Ketamine and Non-Ketamine Using Criminal Offenders Prior to Prison EntryA 'pain-free' death.Can gradual dose titration of ketamine for management of neuropathic pain prevent psychotomimetic effects in patients with advanced cancer?Low-dose ketamine as a potential adjuvant therapy for painful vaso-occlusive crises in sickle cell disease.Ketamine in pain management.Ketamine as an adjuvant to opioids for cancer pain.Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain.Ketamine, as adjuvant analgesics for patients with refractory cancer pain, does affect IL-2/IFN-γ expression of T cells in vitro?: A prospective, randomized, double-blind studyQuantifying the psychological effects of ketamine: from euphoria to the k-Hole.Going beyond efficacy: strategies for cancer pain management.Propofol use in pediatric patients with severe cancer pain at the end of life.Beneficial effect of low-dose ketamine addition to epidural administration of morphine-bupivacaine mixture for cancer pain in two cases.
P2860
Q24197473-7FB9A30F-AFA2-4FF8-9AAD-92BE9BFA7ABDQ24250218-39303502-CF95-480A-8EE1-447F15160C63Q28077524-A35DAAE7-DD6F-4B18-96E9-25C6DAB63413Q34156710-43B22D33-B272-4D67-B884-58EE4942F181Q34554563-8AE46AD1-D16C-4B5C-8373-2D7B73767F6BQ34874438-2A7C553F-6BB3-4817-B058-E1901201EA42Q35020147-6E037058-6391-45B9-AFF3-6DE727BD05BFQ35059783-3EF38292-8526-4A94-8BB0-9972CB2B9753Q35593803-B5F8AFF6-634F-4DEE-AD67-636741FF7B0AQ35685930-C6AF123B-0B6B-4A68-8724-1F0516DAB502Q35751793-9335584C-9267-408C-929F-0133401C2F9FQ36854479-21490774-0F75-4FE6-8FED-74348AFEEBACQ37029155-810D98AE-43FA-47D8-AD39-33056820A5DDQ37126025-8000E782-2039-47B5-BDF4-2FBD112CB250Q37335741-6B7340D8-3F65-4704-8D19-8442DFFBF997Q38029585-41CAB032-0B13-4606-BDBA-AD9BA037AD5DQ38097075-C9425A59-8D23-402E-8A00-1240A72F12A3Q38105649-6A66D504-3B51-450D-A4C3-DA67E9DC8559Q38705422-9FA81EF0-4B7B-4AC7-92DB-C6FE20DC736DQ39202806-0D694EE9-6B8D-4698-80B2-12836E5638C6Q41910230-6FF47AB7-404D-446A-9F08-2888EB47759BQ42840560-EA9739C9-1C48-4FC3-8936-A269451F6479Q42976344-B1582057-1E2F-40D5-8ED2-F9C8E630A0BBQ48634170-47ACE5EA-88A9-49B1-8000-B5EBE1369CA7Q48705623-43CFF2EB-0F7A-479F-8485-5767D16DCA1D
P2860
Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain.
@en
Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain.
@nl
type
label
Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain.
@en
Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain.
@nl
prefLabel
Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain.
@en
Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain.
@nl
P1476
Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain.
@en
P2093
P304
P356
10.1016/S0885-3924(98)00144-4
P577
1999-04-01T00:00:00Z